icine), and Gary Schwartz, PhD (Albert Einstein College of Medicine). As in the past, our AEs and Editorial Board have a wide diversity with respect to gender, geographical locale, and clinical versus basic science expertise. Regardless of their backgrounds, all the AEs are internationally recognized experts in endocrinology and metabolism. You will also note that we have an expanded Editorial Board with wider expertise in all aspects covered by the Journal (see current masthead of this issue for a complete listing). We have reviewed the needs of the Journal and now appoint Editorial Board members for a one-year term. The current board was selected on the basis of recommendations from the AEs and by their uniformly strong past reviewing contributions to AJPEndo or other journals. We welcome nominations for new editorial board members and for ad hoc reviewers wishing to gain editorial experience, because part of our continuing mission is to train the next generation. Collectively, the team feels deeply about the Journal and provides endless hours assisting authors with providing the scientific community with the very best science possible. With an uncertain future, the best resource is to have the right people on your team.
As scientists, we crave the next big discovery. While each of us would like to be the one making the discovery, the next best thing is to read about it. Therefore, the Journal will present only papers of the highest quality to our readers. Over the past three years, papers published in AJPEndo have become more mechanistic in nature, with a diminishing emphasis on studies relying exclusively on correlation and associations. While high-quality descriptive papers will still find a home in the Journal, it is increasingly evident that the availability of sophisticated biochemical, cellular, molecular, and genetic tools will enhance the depth and scope of all studies investigating physiological function and relevance. Despite this emphasis, we wish to assure investigators that the Journal has not lost its focus; we will continue to "dance with who brought us." Therefore, while the above-mentioned reductionist approach certainly provides mechanistic insight, there exist equally important studies to be published that will examine mechanisms using more integrative physiological approaches. Furthermore, the Journal will continue to actively solicit and welcome submission of physiological studies on humans.
One of the most notable achievements at AJPEndo during the past three years has been the publication of an increased number of cutting-edge review-type articles [e.g., full Reviews, Minireviews, and Perspectives (1)]. This trend will continue with the desire to stimulate new and creative ways of looking at specific scientific questions. The Journal has a long-standing and storied history of publishing research related to metabolic changes in glucose, lipid, and protein metabolism. More recently, the metabolic derangements produced by diabetes, obesity, and exercise have become a prominent feature of the Journal. Although this focus is unlikely to change dramatically in the coming years, we will actively work to not marginalize other areas of endocrinology and metabolism. In the coming months and years, you will note an increased number of papers devoted to bone and reproductive metabolism as well as central control of appetite as we strive to emphasize these and other emerging areas. We will continue to publish articles aimed at providing mechanistic answers (at either the cellular or whole body level) in all areas of endocrinology and metabolism using cellular, animal, and human models. This diversity of subject matter and methodology is one of our great strengths and should not be viewed as a limitation. This subject diversity mirrors that of the membership of the American Physiological Society (APS), the American Diabetes Association (ADA), the Endocrine Society, and other related professional societies. The shared purpose of the editor, AEs, and Editorial Board will be to ensure that AJPEndo publishes papers using a range of modern techniques as well as the more successful traditional approaches. We cannot afford to be exclusionists, but instead we aim to attract the very best science, regardless of approach, and so we welcome your submissions. In addition to our research publications, reviews, and letters to the editor, AJPEndo will work with APS to highlight outstanding accomplishments by Society members that are timely and of interest to our readership. For example, we will spotlight review articles stemming from the annual Solomon Berson Award Lecture and the Young Investigator Award selected by the Endocrinology and Metabolism Section of APS. In addition, the EIC and AEs will be visible at other society gatherings (ADA, Endocrine Society, Society for Neuroscience, etc.), and I encourage you to take the opportunity to meet with these individuals.
One "side effect" of the increased number of submissions and a rigorous review process has been the increase in the number of manuscripts rejected by AJPEndo, a rate that now approaches 60%. This figure is certainly reflective of the high quality of the science submitted to the Journal and is more likely to increase than decrease in the coming years. It is realized that as a result more authors will receive the dreaded rejection letter regarding their manuscript submission. While we are sensitive to this issue, it is a necessary evil that accompanies the increased status and recognition of the Journal. All of the journals in the AJP family have created a culture where information flows freely, where authors place their trust in the journals to provide a fair and rapid review of their manuscripts and, whether accepted or rejected, to provide constructive criticism. Our AEs and Editorial Board will strive to provide the best quality reviews in the shortest time-fewer than 19 days from time of first submission. The increased number of manuscripts received by the Journal, however, has necessitated a change in review policy. Therefore, AJPEndo, like many other premier journals, has instituted an "expedited review" category for manuscripts falling into the lower quartile of those submitted. While receiving notification that one's manuscript falls into this category is undoubtedly disappointing, such a strategy is deemed best for the submitting authors because it provides a rapid editorial decision (Ͻ5 days), does not consume valuable reviewer resources, and is best for the Journal's focus. The team is committed to the quality of the Journal and provides endless hours helping authors provide the scientific community with the very best publication possible.
In closing, thanks again to Dr. Klip and her editorial team for their outstanding work and dedication for the past three years. They have set the bar high, but the new team is up to the challenge. In the years ahead, our goal is to simply publish the preeminent journal in endocrinology and metabolism. While we will provide the vehicle, it is up to individual investigators to select AJPEndo as the repository for their very best science. The Journal can be improved, and your comments and concerns are always welcomed. It seems only fitting that an organization that provides constructive suggestions for improvements to its contributors should lead the way in accepting suggestions for its own improvement. All such suggestions can be directed to me (clang@psu.edu) or to any of the AEs in correspondence that is signed or anonymous, and should lead to better accountability. We are excited to work with each of you now and in the future to make AJP -Endocrinology and Metabolism THE go-to journal.
